한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

from "ai+" to efficient drug development:

nanjing purple mountain research institute is committed to combining artificial intelligence technology with drug discovery and design to break through the bottleneck of traditional drug development. they have built a comprehensive "ai+" drug development platform that covers all aspects from target discovery to clinical trials. the core of the platform is to analyze biomedical data through artificial intelligence algorithms, optimize drug design schemes and predict drug effects.

explore a new future of pharmacy:

the innovation of the "ai+" drug development platform is that it can achieve target gene screening and drug design, shorten the development cycle and improve efficiency. this approach also reduces unnecessary experiments, reduces drug costs, and brings safer and more effective drugs to patients.

the advantages of "ai+" in the field of drug research and development:

the "ai+" preclinical drug discovery and design engineering research center proposed by the institute will focus on the following aspects:

• breakthrough in efficient target discovery: artificial intelligence algorithms are used to analyze massive biomedical data and quickly screen out targets with potential drug efficacy.
• intelligent drug molecule design: through simulation and optimization, more efficient and safer drug molecules can be accurately designed to shorten the drug development cycle.
• intelligent clinical trial design: use artificial intelligence technology to predict clinical trial results, improve experimental efficiency and reduce costs.
• large-scale biomedical data processing and integration: integrate biomedical data from multiple sources to form a unified data platform to provide more accurate data support for artificial intelligence models.

the future development direction of “ai+”:

the institute will continue to explore the application of artificial intelligence technology in the field of pharmaceutical research and development, and transform research results into practical products and services. in the future, they will focus on developing more ai-based drug discovery and design tools and apply them to different fields, such as tumor treatment and rare disease treatment.

conclusion:

the "ai+" preclinical drug discovery and design engineering research center of nanjing purple mountain research institute will bring new breakthroughs to pharmaceutical research and development and promote the development of artificial intelligence technology in the pharmaceutical field. this is not only the climax of the institute's move towards scientific and technological innovation, but also represents the future development trend of science and technology empowering medicine, and will make great contributions to the development of human health.